fludarabine has been researched along with Hamartoma Syndrome, Multiple in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hafner, J; Kumar, K; Mulligan, S; Ng, K | 1 |
1 other study(ies) available for fludarabine and Hamartoma Syndrome, Multiple
Article | Year |
---|---|
Multifocal central nervous system demyelination and Lhermitte's phenomenon secondary to combination chemotherapy for chronic lymphocytic leukaemia.
Topics: Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Hamartoma Syndrome, Multiple; Hereditary Central Nervous System Demyelinating Diseases; Humans; Immunologic Factors; Leukemia, Lymphocytic, Chronic, B-Cell; Magnetic Resonance Imaging; Male; Middle Aged; Rituximab; Vidarabine | 2014 |